Fennec Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: FENC
Share price (10/7/26): $10.36
Market cap (10/7/26): $366 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Cioffi Christiana Marie

Sayad Pierre Sargis

Hackman Jeffrey S.

News Filter

Announces Oral Presentation of Detailed Results From Investigator-Initiated Phase 2 Sts-J01 Clinical Study of Pedmark® in Japan at Siop 2026

Shareholder Vote Results

Announces New Research Supporting Integration and Use of Pedmark® at the 2026 Asco Annual Meeting

Announces Inducement Grants Under NASDAQ Listing Rule 5635

Change in Directors, Officers or Compensation

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC